Read + Share
Amedeo Smart
Independent Medical Education
Shimony S, Bewersdorf JP, Shallis RM, Liu Y, et al. Hypomethylating agents plus venetoclax compared with intensive induction chemotherapy regimens in molecularly defined secondary AML. Leukemia 2024;38:762-768.PMID: 38378841
Email
LinkedIn
Facebook
Twitter
Privacy Policy